Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2026-03-26 @ 3:14 PM
Ignite Modification Date:
2026-03-26 @ 3:14 PM
NCT ID:
NCT07471061
Eligibility Criteria:
Inclusion Criteria:
* Adult patients (≥ 18 years old) admitted with a diagnosis of acute ischemic stroke confirmed by brain imaging (CT or MRI).
* Admission within a defined time window from stroke onset (e.g., within 48 hours) to capture acute inflammatory response.
* Availability of complete blood count (CBC) with differential and serum -albumin levels at admission.
* Informed consent obtained from the patient or their legal representative.
Exclusion Criteria:
* Patients with hemorrhagic stroke or transient ischemic attack (TIA).
* Patients with previous history of ischemic stroke.
* Patients who accepted intravenous thrombolysis (IV tPA) and or mechanical thrombectomy.
* Pre-existing inflammatory or autoimmune diseases (e.g., rheumatoid arthritis, lupus, inflammatory bowel disease) that could influence monocyte count or albumin levels.
* Active infections (bacterial, viral, fungal) at admission.
* Severe liver or kidney disease affecting albumin synthesis or catabolism.
* Hematological disorders affecting white blood cell counts. ⚫ Patients on immunosuppressive therapy or corticosteroids.
* Patients with known malignancy
* Lack of complete blood count (CBC) with differential and serum albumin levels at admission.
* Patients who received blood transfusions before blood sampling.
* Patients with other acute severe medical conditions that significantly impact inflammatory markers (e.g., sepsis, major trauma).
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT07471061
Study Brief:
Protocol Section:
NCT07471061